Two Sigma Investments, LP Citius Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.08 - $1.65 $42,153 - $64,401
39,031 New
39,031 $46,000
Q2 2022

Aug 15, 2022
BUY
$0.88 - $1.87 $48,975 - $104,072
55,654 New
55,654 $51,000
Q1 2022

May 16, 2022
SELL
$1.38 - $1.89 $223,504 - $306,104
-161,960 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$1.51 - $2.2 $26,938 - $39,248
17,840 Added 12.38%
161,960 $249,000
Q3 2021

Nov 15, 2021
BUY
$1.74 - $2.6 $250,768 - $374,712
144,120 New
144,120 $293,000

Others Institutions Holding CTXR

# of Institutions
61
Shares Held
23.7M
Call Options Held
83.1K
Put Options Held
32.1K
View Full List

About Citius Pharmaceuticals, Inc.

CTXR Quotes by TradingView
  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $376M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email